Brief: Procaps Q3 Revenue USD 118 Million
26/12/2023 22:40
Dec 26 (Reuters) - Procaps Q3 gross profit USD 68 million. * Q3 adjusted EBITDA USD 22 million * Q3 adjusted EBITDA margin 19% * Q3 gross margin 58%
Recent news on Sofgen Pharma SA
See all newsBrief: Procaps Group Receives Delisting Notice From Nasdaq
Brief: Procaps Group Receives Additional Delinquency Letter
Brief: Procaps Group Announces Key Shareholder And Board Decisions, Committee Restructuring, And Leadership Updates
Brief: Procaps Issues Shareholder Letter Update
Brief: Procaps Issues Shareholder Letter Update